PUF Ventures Inc.’s (TSX-V: PUF) PUF Ventures Australia’s (PUFA) applications for medicinal cannabis licences for its Northern Rivers project in New South Wales, Australia, for both cultivation and production, cannabis research licence, and manufacturing licence have been accepted by the Office of Drug Control (ODC). The applications have now progressed to the assessment phase, all associated fees have been paid. The company will continue to provide updates as appropriate while it progresses through the process.
The company would also like to announce that PUF Ventures Australia will begin operating under a new corporate name and will be known as Solaris Nutraceuticals Pty. Ltd.
“The new name reflects our focus on distinct innovations to provide medicinal cannabis grown under the Northern Rivers sun in our proposed 1.2-million-square-foot Ultra-Clima glass house,” Michael Horsfall, president and chief executive officer, Solaris Nutraceuticals Pty. Ltd. “In addition to our name change, you will see a fresh new look and feel to the corporate image of the company which reflects the innovation, quality and environmentally sustainable products to be developed in our glass house and manufacturing facilities.”
MYM Nutraceuticals and PUF Ventures are co-owners in Solaris Nutraceuticals.
About Solaris Nutraceuticals
Solaris Nutraceuticals is an innovative medical technology company with headquarters in Sydney, Australia. It has proposed plans and applications with Office of Drug Control in Australia to build a 1.2-million-square-foot glass house with a medical research centre and manufacturing facility in the Northern Rivers region of New South Wales. The company’s corporate mission is to deliver an environmentally friendly, sun-grown medicinal-grade cannabis, develop medicines and treatments for pain management and other medical conditions, and produce specific plant-based nutraceuticals. The company’s focus is on innovations that promote, support and deliver improvements in the quality, consistency and cost of medicines to its clients.
About PUF Ventures Inc.
PUF Ventures is a growth-oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg Inc., PUF Ventures Australia, Weed Points Loyalty Inc. and Natures Hemp Corp. and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100 per cent of AAA Heidelberg, a private Ontario company and advanced applicant for an ACMPR (Access to Cannabis for Medical Purposes Regulations) licence. Currently, AAA Heidelberg has not received a licence from Health Canada.